IL1B and inflammatory bowel disease: Since we found the secretion level of IL-6 and IL-1β were dramatically decreased after FFD or TFD treatment in our IBD mice models, we assessed the level of phospho-p65 and phospho-IκBɑ via immunohistochemistry staining of FFD- or TFD-treated IBD model mice.